2023-05-02T04:20:02+03:00[Europe/Moscow] en true <p>Cost-of-illness analysis</p>, <p>can tell you where resources are being used; cannot tell whether it is effective or not</p>, <p>e</p>, <p>knowledge of disease progression, survival probability, current/future projections of incidence rates &amp; treatment patterns </p>, <p>a</p>, <p>b</p>, <p>a</p>, <p>Incidence-based COI</p>, <p>b</p>, <p>a</p>, <p>a</p>, <p>study perspective, discount rate, direct/indirect costs, sensitivity analysis </p>, <p>EMR </p>, <p>Medication Expenditure Panel Survey (MEPS)</p>, <p>Youth Risk Behavior Surveillance System (YRBSS)</p>, <p>data linkage of demographic information &amp; other healthcare services </p>, <p>turnover rate, changes in coding/accuracy</p>, <p>Transactional/Operational data</p> flashcards
Cost-of-illness

Cost-of-illness

  • Cost-of-illness analysis

    -measures the economic burden of a disease and illness on society. Measures the costs of: medical resources to treat disease, non-medical resources, loss in productivity, and intangible cost.

  • can tell you where resources are being used; cannot tell whether it is effective or not

    What can COI analysis tell us about how resources are use?

  • e

    __________ usually do not have an invested interest in COI analysis.

    a) Government

    b) patient

    c) payers

    d) healthcare system

    e) Providers

  • knowledge of disease progression, survival probability, current/future projections of incidence rates & treatment patterns

    What are challenges associated with Incidence-based COI analysis? (3)

  • a

    Which is the best at calculating life-time cost of chronic disease?

    a) incidence-based

    b) prevalence-based

  • b

    Which is the most commonly used COI approach?

    a) incidence-based

    b) prevalence-based

  • a

    Which tells us the life-time disease cost & tracks patients from diagnosis to cure or death?

    a) incidence-based

    b) prevalence-based

  • Incidence-based COI

    -provides a more accurate baseline for estimating the benefits of treatment or preventive programs whose benefits will occur over a long time

  • b

    Which requires less data & fewer assumptions?

    a) incidence-based

    b) prevalence-based

  • a

    If costs extend past one year, _______ will provide information about the cost of averting a case.

    a) incidence-based

    b) prevalence-based

  • a

    Which approach tends to result in a lower cost estimate?

    a) incidence-based

    b) prevalence-based

  • study perspective, discount rate, direct/indirect costs, sensitivity analysis

    What should be included in your study results? (4)

  • EMR

    -a longitudinal collection of person-level health information, maintained by healthcare providers or patients.

  • Medication Expenditure Panel Survey (MEPS)

    -large representative survey of US households and medical providers; includes information on costs and utilization of health care, including Rx.

  • Youth Risk Behavior Surveillance System (YRBSS)

    -monitors six categories of health-related behaviors that contribute to the leading causes of death and disability among youth and adults.

  • data linkage of demographic information & other healthcare services

    What are advantages associated with administrative claims data? (2)

  • turnover rate, changes in coding/accuracy

    What are disadvantages associated with administrative claims data? (2)

  • Transactional/Operational data

    -data that are collected as the result of activities that support the provision of a healthcare service i.e. pharmacy information system, lab results, data maintained by large firm.